Signal Transduction Pathway through Activin Receptors as a Therapeutic Target of Musculoskeletal Diseases and Cancer
Author:
Affiliation:
1. Division for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science (ICMS), Fujita Health University
Publisher
Japan Endocrine Society
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
http://www.jstage.jst.go.jp/article/endocrj/55/1/55_KR-110/_pdf
Reference85 articles.
1. 1. Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D, Spiess J (1986) Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321: 776-779.
2. 2. Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, Guillemin R (1986) Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 321: 779-782.
3. Activins, Myostatin and Related TGF-β Family Members as Novel Therapeutic Targets for Endocrine, Metabolic and Immune Disorders
4. 4. Harrison CA, Gray PC, Vale WW, Robertson DM (2005) Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab 16: 73-78.
5. 5. McDowell N, Gurdon JB (1999) Activin as a morphogen in Xenopus mesoderm induction. Semin Cell Dev Biol 10: 311-317.
Cited by 144 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current and investigational medications for the treatment of sarcopenia;Metabolism;2023-12
2. Generation of locus coeruleus norepinephrine neurons from human pluripotent stem cells;Nature Biotechnology;2023-11-16
3. Growth differentiation factor 11: A new hope for the treatment of cardiovascular diseases;Cytokine & Growth Factor Reviews;2023-06
4. Myostatin: a potential therapeutic target for metabolic syndrome;Frontiers in Endocrinology;2023-05-23
5. The inhibitory function of GDF11/BMP11 in liver cancer by inducing apoptosis and ROS–JNK pathway;Oncologie;2023-02-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3